Published on in Vol 9, No 8 (2020): August
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/16198, first published
.
Journals
- Agutu C, Oduor T, Kombo B, Mugo P, Chira S, Ogada F, Rinke de Wit T, Chege W, van der Elst E, Graham S, Sanders E, Francis J. High patient acceptability but low coverage of provider-initiated HIV testing among adult outpatients with symptoms of acute infectious illness in coastal Kenya. PLOS ONE 2021;16(2):e0246444 View
- Chamie G, Napierala S, Agot K, Thirumurthy H. HIV testing approaches to reach the first UNAIDS 95% target in sub-Saharan Africa. The Lancet HIV 2021;8(4):e225 View
- Sanders E, Agutu C, van der Elst E, Hassan A, Gichuru E, Mugo P, Farquhar C, Babigumira J, Goodreau S, Hamilton D, Ndung'u T, Sirengo M, Chege W, Graham S. Effect of an opt‐out point‐of‐care HIV‐1 nucleic acid testing intervention to detect acute and prevalent HIV infection in symptomatic adult outpatients and reduce HIV transmission in Kenya: a randomized controlled trial. HIV Medicine 2022;23(1):16 View
- Agutu C, Oduor T, Hassan A, Mugo P, Chege W, de Wit T, Sanders E, Graham S. Predictors of testing history and new HIV diagnosis among adult outpatients seeking care for symptoms of acute HIV infection in coastal Kenya: a cross-sectional analysis of intervention participants in a stepped-wedge HIV testing trial. BMC Public Health 2022;22(1) View
- Babigumira J, Agutu C, Hamilton D, van der Elst E, Hassan A, Gichuru E, Mugo P, Farquhar C, Ndung'u T, Sirengo M, Chege W, Goodreau S, Sanders E, M Graham S. Testing strategies to detect acute and prevalent HIV infection in adult outpatients seeking healthcare for symptoms compatible with acute HIV infection in Kenya: a cost-effectiveness analysis. BMJ Open 2022;12(9):e058636 View
- Hamilton D, Agutu C, Babigumira J, van der Elst E, Hassan A, Gichuru E, Mugo P, Farquhar C, Ndung'u T, Sirengo M, Chege W, Goodreau S, Elder A, Sanders E, Graham S. Modeling the Impact of HIV-1 Nucleic Acid Testing Among Symptomatic Adult Outpatients in Kenya. JAIDS Journal of Acquired Immune Deficiency Syndromes 2022;90(5):553 View
- van der Elst E, Abuna M, Agutu C, Ogada F, Galole A, Shikuku J, Oduor T, Graham S, Sanders E, Operario D, Januraga P. “Facilitating HIV status adjustment: Qualitative insights from the Tambua Mapema proof-of-concept study in Kenya”. PLOS ONE 2022;17(1):e0261255 View
- Hamilton D, Agutu C, Sirengo M, Chege W, Goodreau S, Elder A, Sanders E, Graham S. Modeling the impact of different PrEP targeting strategies combined with a clinic-based HIV-1 nucleic acid testing intervention in Kenya. Epidemics 2023;44:100696 View
- Nduva G, Otieno F, Kimani J, Sein Y, Arimide D, Mckinnon L, Cholette F, Lawrence M, Majiwa M, Masika M, Mutua G, Anzala O, Graham S, Gelmon L, Price M, Smith A, Bailey R, Medstrand P, Sanders E, Esbjörnsson J, Hassan A. Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986–2020. Journal of Antimicrobial Chemotherapy 2024;79(2):287 View